Published in Endocr Rev on November 23, 2004
The mammalian ovary from genesis to revelation. Endocr Rev (2009) 2.31
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril (2010) 2.25
Obesity and the pubertal transition in girls and boys. Reproduction (2010) 1.74
Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Hum Reprod Update (2008) 1.30
Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. Nat Commun (2015) 1.09
Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis. Hum Reprod Update (2008) 1.07
Steroid biomarkers and genetic studies reveal inactivating mutations in hexose-6-phosphate dehydrogenase in patients with cortisone reductase deficiency. J Clin Endocrinol Metab (2008) 1.04
Developmental programming: effect of prenatal steroid excess on intraovarian components of insulin signaling pathway and related proteins in sheep. Biol Reprod (2010) 0.95
Contemporary genetic technologies and female reproduction. Hum Reprod Update (2011) 0.95
The use and misuse of matching in case-control studies: the example of polycystic ovary syndrome. Fertil Steril (2007) 0.94
Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies. Metab Syndr Relat Disord (2015) 0.94
Poly Cystic Ovarian Syndrome: An Updated Overview. Front Physiol (2016) 0.90
Childhood obesity and its impact on the development of adolescent PCOS. Semin Reprod Med (2014) 0.89
Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA), a candidate gene for polycystic ovary syndrome. Hum Reprod (2008) 0.88
Preliminary evidence of glycogen synthase kinase 3 beta as a genetic determinant of polycystic ovary syndrome. Fertil Steril (2007) 0.88
Role of haptoglobin in polycystic ovary syndrome (PCOS), obesity and disorders of glucose tolerance in premenopausal women. PLoS One (2009) 0.86
Intergenerational associations of chronic disease and polycystic ovary syndrome. PLoS One (2011) 0.85
Family association study between INSR gene polymorphisms and PCOS in Han Chinese. Reprod Biol Endocrinol (2011) 0.84
Power of proteomics in linking oxidative stress and female infertility. Biomed Res Int (2014) 0.83
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev (2016) 0.83
Socioeconomic status and polycystic ovary syndrome. J Womens Health (Larchmt) (2011) 0.83
The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-gamma. PPAR Res (2007) 0.80
Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome. J Ovarian Res (2014) 0.79
The role of androgen receptor activity mediated by the CAG repeat polymorphism in the pathogenesis of PCOS. J Med Life (2013) 0.79
Predisposition for borderline personality disorder with comorbid major depression is associated with that for polycystic ovary syndrome in female Japanese population. Neuropsychiatr Dis Treat (2011) 0.79
Cellular reprogramming for understanding and treating human disease. Front Cell Dev Biol (2014) 0.78
Genetic, hormonal and metabolic aspects of PCOS: an update. Reprod Biol Endocrinol (2016) 0.78
Heart type fatty acid binding protein response and subsequent development of atherosclerosis in insulin resistant polycystic ovary syndrome patients. J Ovarian Res (2012) 0.77
The mechanism of mTOR (mammalian target of rapamycin) in a mouse model of polycystic ovary syndrome (PCOS). J Ovarian Res (2012) 0.77
Is insulin resistance an intrinsic defect in asian polycystic ovary syndrome? Yonsei Med J (2013) 0.77
A possible role for AMP-activated protein kinase activated by metformin and AICAR in human granulosa cells. Reprod Biol Endocrinol (2015) 0.76
Association of the -243 A-->G polymorphism of the glutamate decarboxylase 2 gene with obesity in girls with premature pubarche. Fertil Steril (2008) 0.76
The Association of -429T>C and -374T>A Polymorphisms in the RAGE Gene with Polycystic Ovary Syndrome. Int J Med Sci (2016) 0.75
Metabolic and carbohydrate characteristics of different phenotypes of polycystic ovary syndrome. J Turk Ger Gynecol Assoc (2016) 0.75
Antimullerian hormone and its receptor gene expression in prenatally androgenized female rats. Int J Endocrinol Metab (2015) 0.75
Endocrinology of hirsutism. Int J Trichology (2010) 0.75
Association of Prooxidant-Antioxidant Balance with Clinical and Laboratory Parameters and Its Relation to Different Drug Regimens in Polycystic Ovary Syndrome Women with Normal BMI. Indian J Clin Biochem (2016) 0.75
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril (2010) 2.25
The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly. J Clin Endocrinol Metab (2009) 1.52
The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J Clin Endocrinol Metab (2005) 1.37
Abdominal adiposity and the polycystic ovary syndrome. Trends Endocrinol Metab (2007) 1.35
Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Arch Intern Med (2006) 1.27
Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2006) 1.16
Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity. J Clin Endocrinol Metab (2004) 1.10
The -597 G-->A and -174 G-->C polymorphisms in the promoter of the IL-6 gene are associated with hyperandrogenism. J Clin Endocrinol Metab (2002) 1.02
Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update (2013) 1.01
Association of polymorphisms in the interleukin 6 receptor complex with obesity and hyperandrogenism. Obes Res (2003) 1.01
A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11beta-hydroxysteroid dehydrogenase type 1 gene 83557insA polymorphisms in the polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 0.97
Comment: the methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism. J Clin Endocrinol Metab (2002) 0.96
Global adiposity and thickness of intraperitoneal and mesenteric adipose tissue depots are increased in women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab (2013) 0.96
Polymorphisms in the interleukin-6 receptor gene are associated with body mass index and with characteristics of the metabolic syndrome. Clin Endocrinol (Oxf) (2006) 0.96
Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC-MS. Clin Chem (2012) 0.92
Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry. Hum Reprod (2007) 0.92
A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs. J Clin Endocrinol Metab (2007) 0.91
Body iron stores are increased in overweight and obese women with polycystic ovary syndrome. Diabetes Care (2005) 0.90
Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome. Fertil Steril (2003) 0.89
Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses. Diabetes Care (2007) 0.88
Long-term treatment of acromegalic patients resistant to somatostatin analogues with the GH receptor antagonist pegvisomant: its efficacy in relation to gender and previous radiotherapy. Eur J Endocrinol (2009) 0.86
Role of haptoglobin in polycystic ovary syndrome (PCOS), obesity and disorders of glucose tolerance in premenopausal women. PLoS One (2009) 0.86
Insulin gene variable number of tandem repeats regulatory polymorphism is not associated with hyperandrogenism in Spanish women. Fertil Steril (2002) 0.84
99MTc-sestamibi as sole technique in selection of primary hyperparathyroidism patients for unilateral neck exploration. Surgery (2008) 0.83
Obesity impairs general health-related quality of life (HR-QoL) in premenopausal women to a greater extent than polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) (2010) 0.83
Evidence for masculinization of adipokine gene expression in visceral and subcutaneous adipose tissue of obese women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab (2013) 0.83
Mutations in the hereditary hemochromatosis gene are not associated with the increased body iron stores observed in overweight and obese women with polycystic ovary syndrome. Diabetes Care (2006) 0.83
Pegvisomant-induced liver injury is related to the UGT1A1*28 polymorphism of Gilbert's syndrome. J Clin Endocrinol Metab (2010) 0.82
Common single nucleotide polymorphisms in intron 3 of the calpain-10 gene influence hirsutism. Fertil Steril (2002) 0.81
Body iron stores and glucose intolerance in premenopausal women: role of hyperandrogenism, insulin resistance, and genomic variants related to inflammation, oxidative stress, and iron metabolism. Diabetes Care (2009) 0.81
Improved resolution of the human adipose tissue proteome at alkaline and wide range pH by the addition of hydroxyethyl disulfide. Proteomics (2004) 0.81
The increase in serum visfatin after bariatric surgery in morbidly obese women is modulated by weight loss, waist circumference, and presence or absence of diabetes before surgery. Obes Surg (2008) 0.79
Diet composition and physical activity in overweight and obese premenopausal women with or without polycystic ovary syndrome. Gynecol Endocrinol (2011) 0.79
The ACAA-insertion/deletion polymorphism at the 3' UTR of the IGF-II receptor gene is associated with type 2 diabetes and surrogate markers of insulin resistance. Eur J Endocrinol (2006) 0.79
Proteomics and genomics: A hypothesis-free approach to the study of the role of visceral adiposity in the pathogenesis of the polycystic ovary syndrome. Proteomics Clin Appl (2008) 0.77
The PON1-108C/T polymorphism, and not the polycystic ovary syndrome, is an important determinant of reduced serum paraoxonase activity in premenopausal women. Hum Reprod (2006) 0.77
Adrenal Hyperandrogenism and Polycystic Ovary Syndrome. Curr Pharm Des (2016) 0.76
Differences in analytical and biological results between older and newer lots of a widely used irisin immunoassay question the validity of previous studies. Clin Chem Lab Med (2016) 0.76
The decrease in serum IL-18 levels after bariatric surgery in morbidly obese women is a time-dependent event. Obes Surg (2007) 0.75
Serum osteoprotegerin concentrations are decreased in women with the polycystic ovary syndrome. Eur J Endocrinol (2008) 0.75
Genetic basis of metabolic abnormalities in polycystic ovary syndrome: implications for therapy. Am J Pharmacogenomics (2004) 0.75
Cost of clinical management of acromegaly in Spain. Clin Drug Investig (2012) 0.75
Recurrent hyponatremia as the presenting feature of a pituitary abscess: A case report. Endocrinol Nutr (2010) 0.75
Serum visceral adipose tissue-derived serine protease inhibitor concentrations in human obesity and polycystic ovary syndrome. Diabetes Care (2009) 0.75
[Rare adverse effect of discontinuation of levothyroxine treatment for 131I ablation of thyroid remnant in a patient with differentiated thyroid cancer]. Endocrinol Nutr (2012) 0.75
[Metastasis in the thyroid gland]. Cir Esp (2009) 0.75
Role of androgen-mediated enhancement of erythropoiesis in the increased body iron stores of patients with polycystic ovary syndrome. Fertil Steril (2011) 0.75